<code id='ACEE231D7C'></code><style id='ACEE231D7C'></style>
    • <acronym id='ACEE231D7C'></acronym>
      <center id='ACEE231D7C'><center id='ACEE231D7C'><tfoot id='ACEE231D7C'></tfoot></center><abbr id='ACEE231D7C'><dir id='ACEE231D7C'><tfoot id='ACEE231D7C'></tfoot><noframes id='ACEE231D7C'>

    • <optgroup id='ACEE231D7C'><strike id='ACEE231D7C'><sup id='ACEE231D7C'></sup></strike><code id='ACEE231D7C'></code></optgroup>
        1. <b id='ACEE231D7C'><label id='ACEE231D7C'><select id='ACEE231D7C'><dt id='ACEE231D7C'><span id='ACEE231D7C'></span></dt></select></label></b><u id='ACEE231D7C'></u>
          <i id='ACEE231D7C'><strike id='ACEE231D7C'><tt id='ACEE231D7C'><pre id='ACEE231D7C'></pre></tt></strike></i>

          explore

          explore

          author:knowledge    Page View:544
          STR/AFP via Getty Images

          A traditional Chinese medicine compound used for cardiac benefits might help reduce the incidence of major adverse cardiac and cerebrovascular events and even cardiac death rates, according to a new study published Tuesday in the Journal of the American Medical Association.

          However, some outside experts expressed skepticism about the result.

          advertisement

          Tongxinluo — which means “to open (tong) the network (luo) of the heart (xin)” in Mandarin —  is a traditional Chinese medicine compound made out of a mixture of powders and extracts from plants, centipedes, cicadas, and other sources.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          FDA poised to publish guidelines for clinical trial diversity
          FDA poised to publish guidelines for clinical trial diversity

          AdobeTheFoodandDrugAdministrationispoisedtotelldrugandmedicaldevicemakershowtobetterincludepeopleofc

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

          CytokineticsCEORobertBlumspokelastweekatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG